Description
OpenClaw before 2026.4.8 contains an improper authorization vulnerability where the node.pair.approve method accepts operator.write scope instead of the narrower operator.pairing scope, allowing unprivileged users to approve node pairing. Attackers with operator.write permissions can bypass pairing approval restrictions to gain unauthorized access to exec-capable nodes.
Published: 2026-04-28
Score: 8.7 High
EPSS: n/a
KEV: No
Impact: Authorization Bypass – unprivileged users can approve node pairing and gain unauthorized exec‑capable node access
Action: Immediate Patch
AI Analysis

Impact

The vulnerability resides in OpenClaw nodes where the node.pair.approve function accepts an operator.write scope rather than the intended operator.pairing scope. Consequently, individuals who possess only operator.write privileges can trigger node pairing approval without higher authorization. This flaw allows attackers to initiate pairing with exec‑capable nodes, effectively granting them control over those nodes.

Affected Systems

Affected systems are OpenClaw installations using versions earlier than 2026.4.8. The flaw exists across the core node.js implementation, as indicated by the CPE entry for the OpenClaw node.js component. Administrators should verify that their deployment is on a protected version; any deployment prior to 2026.4.8 is susceptible.

Risk and Exploitability

The CVSS score of 8.7 classifies the flaw as high severity. While no EPSS value is supplied, the absence of exploit data does not diminish risk, as the issue permits full authorization bypass and unlocks nodes that can execute commands. Attackers need only to hold an operator.write token—an access level that can be held by many users in the platform. Since the weakness has not been listed in CISA KEV and no public exploit code is known, the likely attack vector involves a legitimate but malicious use of the API by a compromised operator.write user. Administrators should treat this as a critical patch priority.

Generated by OpenCVE AI on April 28, 2026 at 22:54 UTC.

Remediation

No vendor fix or workaround currently provided.

OpenCVE Recommended Actions

  • Upgrade OpenClaw to version 2026.4.8 or later, which corrects the authorization check for node.pair.approve.
  • If an immediate upgrade is not possible, remove or restrict the operator.write scope for all users except those who absolutely need it, until a patch is applied.
  • Disable the node.pair.approve functionality or block the API endpoint until the fix is deployed, to prevent unauthorized pairing from occurring.

Generated by OpenCVE AI on April 28, 2026 at 22:54 UTC.

Tracking

Sign in to view the affected projects.

Advisories

No advisories yet.

History

Tue, 28 Apr 2026 19:15:00 +0000

Type Values Removed Values Added
Description OpenClaw before 2026.4.8 contains an improper authorization vulnerability where the node.pair.approve method accepts operator.write scope instead of the narrower operator.pairing scope, allowing unprivileged users to approve node pairing. Attackers with operator.write permissions can bypass pairing approval restrictions to gain unauthorized access to exec-capable nodes.
Title OpenClaw < 2026.4.8 - Improper Authorization in node.pair.approve via operator.write Scope
First Time appeared Openclaw
Openclaw openclaw
Weaknesses CWE-863
CPEs cpe:2.3:a:openclaw:openclaw:*:*:*:*:*:node.js:*:*
Vendors & Products Openclaw
Openclaw openclaw
References
Metrics cvssV3_1

{'score': 8.8, 'vector': 'CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H'}

cvssV4_0

{'score': 8.7, 'vector': 'CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N'}


Subscriptions

Openclaw Openclaw
cve-icon MITRE

Status: PUBLISHED

Assigner: VulnCheck

Published:

Updated: 2026-04-28T18:10:15.633Z

Reserved: 2026-04-27T11:38:59.195Z

Link: CVE-2026-42426

cve-icon Vulnrichment

No data.

cve-icon NVD

Status : Awaiting Analysis

Published: 2026-04-28T19:37:46.360

Modified: 2026-04-28T20:10:23.367

Link: CVE-2026-42426

cve-icon Redhat

No data.

cve-icon OpenCVE Enrichment

Updated: 2026-04-28T23:00:13Z

Weaknesses